IBD drug companies by number in development November 2019

Select pharmaceutical companies by number of inflammatory bowel disease drugs in development as of November 2019

Pharma companies with IBD drugs in development by number 2019

Last update:

Aug 12, 2020

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2019 to 31/12/2019

As of November 2019, both Janssen and Pfizer dominated the market and each had five IBD drugs in various phases of development. This statistic depicts selected leading pharmaceutical companies in the market of inflammatory bowel disease (IBD) treatments, by number of drugs in development.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Select pharmaceutical companies by number of inflammatory bowel disease drugs in development as of November 2019

Get in touch with us for additional information

��ƽ��